We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

21 hedge funds and large institutions have $7.13M invested in NeuroMetrix, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

498% more capital invested

Capital invested by funds: $1.19M → $7.13M (+$5.94M)

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

50% more funds holding

Funds holding: 14 → 21 (+7)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

Holders
21
Holders Change
+7
Holders Change %
+50%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.47M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$393K
3
SSA
Schonfeld Strategic Advisors
New York
+$341K
4
BlackRock
BlackRock
New York
+$321K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$265K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$928K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$103K
3
Citadel Advisors
Citadel Advisors
Florida
-$98K
4
UBS Group
UBS Group
Switzerland
-$76.9K
5
Morgan Stanley
Morgan Stanley
New York
-$48.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.82M +$3.47M +38,781 +468%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$704K +$265K +2,963 +52%
Renaissance Technologies
3
Renaissance Technologies
New York
$679K -$928K -10,375 -55%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$355K +$393K +4,387 New
SSA
5
Schonfeld Strategic Advisors
New York
$309K +$341K +3,813 New
BlackRock
6
BlackRock
New York
$304K +$321K +3,587 +2,285%
VF
7
Virtu Financial
New York
$237K +$121K +1,357 +87%
Squarepoint
8
Squarepoint
New York
$220K +$242K +2,708 New
SFI
9
Susquehanna Fundamental Investments
Pennsylvania
$144K +$159K +1,778 New
Verition Fund Management
10
Verition Fund Management
Connecticut
$110K +$121K +1,351 New
Millennium Management
11
Millennium Management
New York
$106K +$117K +1,303 New
State Street
12
State Street
Massachusetts
$106K +$117K +1,309 New
TRCT
13
Tower Research Capital (TRC)
New York
$12K +$8.77K +98 +188%
UBS Group
14
UBS Group
Switzerland
$11K -$76.9K -859 -86%
Morgan Stanley
15
Morgan Stanley
New York
$9K -$48.9K -546 -83%
Osaic Holdings
16
Osaic Holdings
Arizona
$3K -$11.6K -130 -77%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$3K +$3.4K +38 New
HI
18
Harbour Investments
Wisconsin
$1K +$984 +11 New
ODG
19
O'Dell Group
Ohio
$1K +$1.16K +13 New
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
– -$103K -3,746 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$98K -3,598 Closed
PA
22
Parallel Advisors
California
– +$89 +1 New
Wells Fargo
23
Wells Fargo
California
– +$89 +1 +33%

NURO Hedge Fund Activity: Q3 2021 in Review

21 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2021, worth a combined $7.13M — up 498% from $1.19M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NURO positions and 4 closed out — a net gain of 7 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.47M. The largest seller was Renaissance Technologies, cutting an estimated $928K.

  • 21 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2021, up from 14 in Q2 2021.
  • Funds reported $7.13M of NeuroMetrix, Inc. Common Stock stock for Q3 2021, up 498% quarter-over-quarter.
  • 11 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of +7 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2021 was Vanguard Group, an estimated $3.47M added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2021 was Renaissance Technologies, an estimated $928K sold.

Based on aggregated 13F filings for Q3 2021.